SARS CoV-2 (COVID-19) Serology

Point of Care External Quality Assurance

The RCPAQAP is pleased to announce the release of the Point of Care External Quality Assurance Program for COVID-19 serology (IgG/IgM) devices.

Key Features:

Allows for post market surveillance of all SARS CoV-2 (COVID-19) serology point of care devices
Results can be submitted from any smart device
Assessment provided in real time
Dedicated team to assist in trouble-shooting
Meets regulatory framework requirements for external quality assurance testing
Allows for the monitoring of lot numbers and users
Organisations are able to review results across multiple sites
Facilitates competency assessment of users
Certificate of Completion is provided

Fill in the fields below and we will get back to you with a quote in the next couple of days.

Name*
First Last
Company*
Phone*
Email*
Shipping Address (full address is required to provide a quote)*
Street Address Address Line 2 City State Postcode